Updates are available Correction dated 2020-07-01
Click to view Correction: https://doi.org/10.1007/s10557-020-07029-2
-
Authors
Yurista, Salva R. http://orcid.org/0000-0001-9126-739X
Silljé, Herman H. W.
Nijholt, Kirsten T.
Dokter, Martin M.
van Veldhuisen, Dirk J.
de Boer, Rudolf A.
Westenbrink, B. Daan
-
Funding
Funding for this research was provided by:
Indonesia Endowment Fund for Education (LPDP No. 20150722083422)
Hartstichting (CVON DOSIS, grant 2014-40, CVON SHE-PREDICTS-HF, grant 2017-21, and CVON RED-CVD, grant 2017-11)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO VIDI, grant 917.13.350, NWO VENI, grant 016.176.147)
- License Information
-
More Information
Article History
First Online: 26 May 2020
Change Date: 1 July 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10557-020-07029-2
Compliance and Ethical Standard
:
: The study was approved by the University of Groningen Ethical Committee on Animal Experimentation (IvD number: 16487-02-001). The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health and in accordance with national regulations.
: SRY, HHWS, KTN, MMD, DJvV and BDW do not report conflicts of interest relative to this report. The UMCG, which employs Dr. De Boer, has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Roche, Trevena and ThermoFisher GmbH. Dr. de Boer received personal fees from MandalMed Inc., Novartis and Servier.
: The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.
